Gynostemma pentaphyllum.
Same as jiaogulan. The AMPK-activating tea. A climbing vine drunk as jiaogulan tea. Its gypenosides are studied against AMPK, the cell's energy sensor, for glucose and lipid measures already in the normal range.
Reviewed March 2026
- Category
- Herb
- Also filed under
- AMPKLongevityMetabolism
What Gynostemma pentaphyllum is, and what it does.
- Does it work
- It suits people who want a caffeine-free daily infusion or extract sitting behind steady energy and metabolic measures already in the normal range.
- How much to take
- Start with 225 to 450mg a day of a gypenoside-standardised extract. The 900mg used in trials is a research condition. As tea, it is a plain infusion of the dried leaf.
- Time to feel it
- Give it four weeks. Trials run four to twelve weeks on metabolic markers, and most of what shifts shows up on a blood panel rather than in how your day feels.
- The first dose
- Mild. Drunk as tea the leaf tastes sweet and grassy, and some people notice a settled, unstimulated calm within the hour.
- With regular use
- Four to twelve weeks of daily use is the studied window. What moves is metabolic measures on a blood panel, plus a steadier feel to the afternoon for some people.
- How well tolerated
- Well tolerated in trials, with mild stomach upset the usual report. If you take glucose-lowering or blood-thinning medicine, check with a clinician before adding it.
- How it feels
- Level rather than noticeable. No lift and no drowsiness, more a sense that energy holds through the afternoon instead of dipping.
- The overlooked benefit
- The leaf is naturally sweet from its own saponins, so it makes a caffeine-free infusion that needs nothing added to it.
225 to 450mg a day is where Gynostemma pentaphyllum works.
Source: Huyen et al. Horm Metab Res 2010; Choi et al. Obesity 2014
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 12 human trials.
- Healthy glucose metabolismRandomised trial
- Cholesterol and triglycerides already in the normal rangeRandomised trial
- Body composition and body weight alongside dietRandomised trial
- AMP-activated protein kinase signallingAnimal study
- Everyday stress and fatigue measuresRandomised trial
Questions people ask about Gynostemma pentaphyllum.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Gynostemma gypenosides include several of the same dammarane saponins found in Panax ginseng, so the two supply overlapping saponin chemistry. Total saponin load adds rather than acting independently.
Both converge on AMPK, the cellular energy sensor that shifts fuel handling toward glucose uptake and fatty acid oxidation. Activating the same switch from two directions makes the effect on normal glucose handling additive.
Gymnemic acids act at the gut and the sweet taste receptor to slow sugar entry, while gypenosides act inside the cell on AMPK signalling. The two sit at different points of the same normal glucose-handling sequence.
Chromium participates in normal insulin receptor signalling, the step downstream of the glucose uptake that gypenosides encourage. Supplying the trace mineral covers a cofactor requirement the botanical does not.
Alpha lipoic acid influences the same AMPK signalling and also recycles cellular antioxidants, which supports the antioxidant enzyme induction gypenosides drive. The pairing covers both the signalling and the redox side.
Schisandra lignans inhibit CYP3A4 and P-glycoprotein, so exposure to co-taken plant actives including gypenosides can run higher than the label dose suggests. The two are also long-standing partners in tonic formulas for normal stamina.
Cinnamon polyphenols and gypenosides both nudge normal glucose handling downward through different routes. Stacked in one formula the effect adds, which matters for anyone already watching low readings.
Silymarin stabilises hepatocyte membranes while gypenosides raise the cell's own antioxidant enzyme output. The two act at different layers of normal liver antioxidant defence.
Catechins engage the same AMPK signalling that gypenosides activate, so the two reinforce one another on cellular fuel handling. Neither supplies the other's chemistry, so the pairing broadens the input rather than doubling a dose.
Gypenosides are described as activators of AMP-activated protein kinase, and resveratrol is discussed in the same energy-sensing literature through sirtuin and AMPK signalling. The overlap is at the pathway level in laboratory work. No human study has tested the two together.
Quercetin is a flavonol with reported activity on mitochondrial biogenesis signalling, which is the same territory the gypenoside literature occupies. The pairing appears in metabolic and endurance formulas. Read it as mechanistic overlap rather than a measured combination.
Coenzyme Q10 is the mobile electron carrier between complexes I and III of the respiratory chain, so it sits directly downstream of anything that increases mitochondrial demand. Gynostemma work has reported effects on mitochondrial respiration. The CoQ10 role is settled biochemistry; the pairing itself is untested.
Carnitine is required to shuttle long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. A formula aimed at fat utilisation depends on that transport step being supplied. The carnitine mechanism needs no citation; the combination has not been trialled.
Nicotinamide riboside is a precursor to NAD, the cofactor the respiratory chain and the sirtuins both depend on. Where gypenosides are described as raising mitochondrial activity, NAD availability is the upstream constraint. The precursor relationship is established; the pairing is a mechanistic proposal.
Caffeine is the usual partner in exercise and body-composition formulas, and Gynostemma has been studied in an exercise-performance context. Their mechanisms are unrelated, so the effects are stacked rather than synergistic. Total stimulant load across a product is the thing to watch.
Both are grouped as adaptogenic plants and appear together in stress and stamina formulas. The pairing rests on shared category rather than on a combination study. It is a traditional-pairing row.
Ashwagandha withanolides and Gynostemma gypenosides are both triterpenoid-class saponins used in stress-support blends, and both have small human literatures of their own. Nothing has tested them together. The pairing is formulation convention.
Astragalus and jiaogulan appear together in traditional Chinese tonic preparations. The rationale is shared traditional usage, not a shared molecular target. No combination evidence exists.
Taurine is concentrated in mitochondria where it participates in tRNA modification needed for the correct translation of respiratory chain subunits. That role is independent of anything Gynostemma does, which is why the two are stacked rather than combined. The pairing is mechanistic and untested.
Every ATP molecule is biologically active as a magnesium complex, so magnesium status is a floor beneath any energy-metabolism formula. This is textbook biochemistry rather than a Gynostemma-specific interaction. It is why magnesium appears in so many metabolic blends.
Dietary nitrate is reduced to nitrite and then nitric oxide, and has been studied for exercise efficiency. Gynostemma has its own small exercise-performance literature through a different route. Stacking them in a pre-exercise formula is a design choice with no combination data behind it.
Nothing specific on file for Gynostemma pentaphyllum. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Gynostemma pentaphyllum actually does.
Gynostemma's signature compounds, the gypenosides, are close chemical cousins of the ginsenosides in ginseng, which is why the plant gets called ginseng-like without actually being a ginseng.
These saponins make water foam, so extracts are standardised by their measured gypenoside percentage rather than by total dry weight.
AMPK is the cell's fuel gauge; when energy runs low it switches on and steers the cell toward burning fuel, including fat, instead of building and storing.
Heat-processing the leaf trims sugar groups off the parent saponins and shifts them into a different set, so a heat-processed extract carries a measurably different profile from a raw one.
Getting Gynostemma pentaphyllum from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Gynostemma pentaphyllum supplementation increased exercise performance measures and altered mitochondrial respiration and AMPK signalling in the participants studied.Randomised trial. Nayyar et al., 2023 (Nutrients). PMID 38004115 ↗
- An orally dosed Gynostemma pentaphyllum extract was tested against placebo for body composition change in adults carrying excess body weight, and the authors report the composition outcomes measured over the trial period.Randomised trial. Rao et al., 2022 (Journal of Human Nutrition and Dietetics). PMID 34323337 ↗
- Supplementation with Gynostemma pentaphyllum leaf extract was associated with lower self-reported anxiety questionnaire scores than placebo in healthy adults under chronic psychological stress.Randomised trial. Choi et al., 2019 (Phytomedicine). PMID 30599899 ↗
- A review of gypenosides collates the pharmacological activity reported for this triterpenoid group and the mechanisms proposed for it, most of it from preclinical work.Narrative review. Li et al., 2025 (Frontiers in Pharmacology). PMID 41181612 ↗
- A review describes anti-inflammatory, antioxidant and neurotransmitter-related mechanisms proposed for gypenosides in relation to peripheral and central fatigue.Narrative review. Li et al., 2025 (Food Science and Nutrition). PMID 40535920 ↗
- A heat-processed Gynostemma pentaphyllum extract showed anti-inflammatory activity in the laboratory models tested, and the processing altered its saponin profile.In vitro study. Lee et al., 2025 (International Journal of Molecular Sciences). PMID 41009707 ↗
- Dietary Gynostemma pentaphyllum supplementation was associated with changes in serum biochemical indexes, egg quality and liver transcriptome profiles in the birds studied.Animal study. Li et al., 2021 (Genes). PMID 34946891 ↗
- Total saponins of Gynostemma pentaphyllum reduced markers of thymus and spleen inflammation in birds held under chronic heat stress.Animal study. Ding et al., 2026 (Poultry Science). PMID 41905078 ↗
- A review of herbal preparations used for circulatory support names Gynostemma among the plants covered and summarises the reported pharmacology.Narrative review. Kaur et al., 2025 (Current Cardiology Reviews). PMID 39229989 ↗
These are the studies our verdict leans on, chosen from the 9 we read for Gynostemma pentaphyllum. The full linked list is below.
The studies, linked.
6 sources behind our Gynostemma pentaphyllum verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialActiponin Supplementation Reduces Abdominal Fat Area, Weight, Body Fat Mass and BMI in Obese Korean Subjects.ClinicalTrials.gov ↗PHASE2 · 80 participants · Completed
- Clinical trialEfficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced StrainClinicalTrials.gov ↗NA · 72 participants · Completed
- Clinical trialAnti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic PatientsClinicalTrials.gov ↗PHASE1 · 25 participants · Completed
- Clinical trialAnti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic PatientsClinicalTrials.gov ↗PHASE1 · 24 participants · Completed
- Clinical trialGynostemma Pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic PatientsClinicalTrials.gov ↗PHASE1 · 16 participants · Completed
- Clinical trialAn Intervention Study of Gynostemma Pentaphyllum in Patients With Metabolic SyndromeClinicalTrials.gov ↗NA · 150 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
